XOMA Royalty Dirección

Dirección controles de criterios 1/4

El CEO de XOMA Royalty es Owen Hughes , nombrado en Jan 2023, tiene una permanencia de 1.83 años. compensación anual total es $2.48M, compuesta por 5% salario y 95% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.3% de las acciones de la empresa, por valor de €1.04M. La antigüedad media del equipo directivo y de la junta directiva es de 1.8 años y 5.8 años, respectivamente.

Información clave

Owen Hughes

Chief Executive Officer (CEO)

US$2.5m

Compensación total

Porcentaje del salario del CEO	5.0%
Permanencia del CEO	1.8yrs
Participación del CEO	0.3%
Permanencia media de la dirección	1.8yrs
Promedio de permanencia en la Junta Directiva	5.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Owen Hughes en comparación con los beneficios de XOMA Royalty?
Fecha	Compensación total	Salario	Ingresos de la empresa
Sep 30 2024	n/a	n/a	-US$35m
Jun 30 2024	n/a	n/a	-US$24m
Mar 31 2024	n/a	n/a	-US$42m
Dec 31 2023	US$2m	US$125k	-US$46m

Compensación vs. Mercado: La compensación total de Owen($USD2.48M) está por encima de la media de empresas de tamaño similar en el mercado German ($USD995.28K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Owen con los resultados de la empresa.

CEO

Owen Hughes (49 yo)

1.8yrs

Permanencia

US$2,482,735

Compensación

Mr. Owen P. Hughes, Jr. serves as Chief Executive Officer of XOMA Royalty Corporation (formerly known as XOMA Corporation) from January 2024 and serves as its Director since January 01, 2023 and served as...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Thomas Burns	Senior VP of Finance & CFO	9.6yrs	US$2.27m	0.12% € 430.8k
Brad Sitko	Chief Investment Officer	1.8yrs	US$8.56m	0.060% € 210.2k

1.8yrs

Permanencia media

49yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de X0M1 no se considera experimentado ( 1.8 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Owen Hughes	CEO & Director	1.8yrs	US$2.48m	0.30% € 1.0m
Jack Wyszomierski	Independent Chairman	14.3yrs	US$232.53k	0.055% € 191.3k
Joseph Limber	Independent Director	11.9yrs	US$210.04k	0.053% € 183.8k
Matthew Perry	Independent Director	7.8yrs	US$197.54k	0.10% € 349.2k
Barbara Kosacz	Independent Director	5.8yrs	US$196.04k	0% € 0
Heather Franklin	Independent Director	3.3yrs	US$203.95k	0% € 0
Natasha Hernday	Independent Director	4.3yrs	US$207.64k	0% € 0

5.8yrs

Permanencia media

58yo

Promedio de edad

Junta con experiencia: La junta directiva de X0M1 se considera experimentada (5.8 años de antigüedad promedio).

XOMA Royalty Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Insufficient new directors

XOMA Corporation, Annual General Meeting, May 15, 2024

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

XOMA Corporation, Annual General Meeting, May 18, 2022

CEO & Director recently sold €254k worth of stock

Recent updates

Third quarter 2024 earnings released: US$1.59 loss per share (vs US$0.60 loss in 3Q 2023)

Insufficient new directors

New minor risk - Shareholder dilution

Second quarter 2024 earnings released: EPS: US$1.37 (vs US$0.59 loss in 2Q 2023)

First quarter 2024 earnings released: US$0.86 loss per share (vs US$0.98 loss in 1Q 2023)

XOMA Corporation (NasdaqGM:XOMA) completed the acquisition of Kinnate Biopharma Inc. (NasdaqGS:KNTE).

XOMA Corporation, Annual General Meeting, May 15, 2024

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

XOMA Corporation (NasdaqGM:XOMA) entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. (NasdaqGS:KNTE) for approximately $120 million.

Xoma Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

XOMA Corporation (NasdaqGM:XOMA) announces an Equity Buyback for $50 million worth of its shares.

New minor risk - Profitability

Third quarter 2023 earnings released: US$0.60 loss per share (vs US$0.48 loss in 3Q 2022)

New major risk - Revenue and earnings growth

Second quarter 2023 earnings released: US$0.59 loss per share (vs US$0.53 loss in 2Q 2022)

First quarter 2023 earnings released: US$0.98 loss per share (vs US$0.32 loss in 1Q 2022)

Full year 2022 earnings released: US$1.50 loss per share (vs US$0.69 profit in FY 2021)

Investor sentiment improved over the past week

XOMA Corporation Appoints Owen Hughes as Interim Chief Executive Officer

Investor sentiment improved over the past week

Third quarter 2022 earnings released: US$0.48 loss per share (vs US$0.51 loss in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Second quarter 2022 earnings released: US$0.53 loss per share (vs US$0.31 loss in 2Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

XOMA Corporation(NasdaqGM:XOMA) dropped from Russell 2000 Dynamic Index

First quarter 2022 earnings released: US$0.32 loss per share (vs US$0.70 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

XOMA Corporation, Annual General Meeting, May 18, 2022

Now 22% undervalued

Investor sentiment improved over the past week

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Third quarter 2021 earnings released: US$0.51 loss per share (vs US$0.098 loss in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Second quarter 2021 earnings released: US$0.31 loss per share (vs US$0.33 loss in 2Q 2020)

CEO & Director recently sold €254k worth of stock

First quarter 2021 earnings released: US$0.70 loss per share (vs US$0.49 loss in 1Q 2020)

Full year 2020 earnings released: EPS US$0.82 (vs US$0.23 loss in FY 2019)

Revenue beats expectations

New 90-day high: €29.32

XOMA Earns First Milestone Payment from 2018 Royalty Purchase Agreement

Revenue misses expectations

Third quarter 2020 earnings released: US$0.098 loss per share

New 90-day high: €20.84

XOMA Corporation Earns $25 Million Milestone Payment

XOMA Corporation announced that it has received $1.4 million in funding from Rezolute, Inc.

New 90-day high: €17.92

XOMA Corporation to Report Q2, 2020 Results on Aug 06, 2020

Earnings released

New 90-day low - €14.03

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad